Non-Interventional Study Among Users Of LoFric Origo

CompletedOBSERVATIONAL
Enrollment

423

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

March 31, 2015

Conditions
Intermittent Catheterization
Interventions
DEVICE

LoFric Origo

Trial Locations (19)

1020

Centre de Traumatologie et de Readaptation, Brussels

1450

Sunnaas Sykehus HF Urodynamisk laboratorium, Nesoddtangen

1478

Akershus Universitetssykehus HF Urologisk poliklinikk, Lørenskog

1951

Clinique romande de réadaptation, Sion

3000

UZ Leuven, Leuven

4000

Centre Hospitalier Universitaire de Liège, Domaine Universitaire du Sart Tilman, Liége

4068

Stavanger Universitetssjukehus, Urologisk poliklinikk, Stavanger

6207

Schweizer Paraplegiker-Zentrum, Neuro-Urologie, Nottwil

6500

U.M.C. St. Radboud, Nijmegen

33000

Groupe Urologique de la Clinique Saint Augustin, Cabinet de Neuro-Urologie, Bordeaux

69230

Hôpital Henry Gabrielle, Unité A1 - Service de Rééducation Périnéale et Sexologique, Saint-Genis-Laval

75020

Hôpital Tenon, Service de Neuro-Urologie et Explorations Périnéales, Paris

92380

Hôpital Raymond Poincaré, Service de Neuro-Urologie, Urologie et Sexologie, Garche

4204 AA

Rivas Zorggroep, Gorinchem

Unknown

Oslo Universitetssykehus HF - Rikshospitalet Urologisk poliklinikk, Oslo

CV2 2DX

University Hospitals Coventry and Warwickshire NHS Trust Walsgrave Hospital, Coventry

TA1 5DA

Musgrove Park Hospital, Taunton

EX2 5DW

Exeter RD&E Hospital, Exeter

WC1N 3GB

National Hospital for Neurology and Neurosurgery Queens Square, London

All Listed Sponsors
lead

Wellspect HealthCare

INDUSTRY

NCT01796587 - Non-Interventional Study Among Users Of LoFric Origo | Biotech Hunter | Biotech Hunter